Civic AI
Procurement intelligence
Federal contract award
TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIORITY OF A NEW VACCINE STRAIN VERSUS THE PROTOTYPE STRAIN
GLAXOSMITHKLINE, LLC · Department of Health and Human Services
- Value
- $493,470
- Start
- Mar 13, 2026
- End
- Oct 29, 2026
- Action date
- Mar 30, 2026
- PIID
- 75A50126F61020
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- DURHAM, NC
- Award type
- DELIVERY ORDER
Description
TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIORITY OF A NEW VACCINE STRAIN VERSUS THE PROTOTYPE STRAIN
Need modifications, related awards, and vendor peers? Open the full award workspace.